Product Images Sildenafil

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 9 images provide visual information about the product associated with Sildenafil NDC 45865-833 by Medsource Pharmaceuticals, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

pdp - 833

pdp - 833

figure-10 - sildenafil fig 10

figure-10 - sildenafil fig 10

figure-11 - sildenafil fig 11

figure-11 - sildenafil fig 11

fig-12 - sildenafil fig 12

fig-12 - sildenafil fig 12

fig-6 - sildenafil fig 6

fig-6 - sildenafil fig 6

fig-8 - sildenafil fig 8

fig-8 - sildenafil fig 8

The text appears to be a chart of different drugs and their recommended dosages with some additional information on interactions and fold change with 90% CI. It also includes a note on the lack of benefit when sildenafil is added to bosentan therapy and the effect of ritonavir on sildenafil PK.*

figure-9 - sildenafil fig 9

figure-9 - sildenafil fig 9

figure-7 - sildenafil figure 7

figure-7 - sildenafil figure 7

This text provides information on drug interactions and recommended dose adjustments. It includes specific drugs such as Atorvastatin, Astromycin, Bosentan, Cimetidine, Evermyel:f and Saquinavir, and outlines whether a dose adjustment is necessary or not. Oral contraceptives are also mentioned, and although no dose adjustment is recommended, co-administration is not recommended. The text displays a chart with a vertical line at x=1 and a note stating that no benefit on exercise capacity is observed when sildenafil is added to bosentan therapy.*

str - sildenafil str

str - sildenafil str

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.